Colorado § 25.5-2.5-205 Federal approval

Colorado Statutes

§ 25.5-2.5-205 — Federal approval

Colorado § 25.5-2.5-205

Title 25.5Health

Art.Prescription Drugs

This text of Colorado § 25.5-2.5-205 (Federal approval) is published on Counsel Stack Legal Research, covering Colorado primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Colo. Rev. Stat. § 25.5-2.5-205 (2026).

Text

(1)On or before September 1, 2020, the state department shall submit a request to the United States secretary of health and human services for approval of the program under 21 U.S.C. sec. 384. The state department shall begin operating the program not later than six months after receiving such approval. The request must, at a minimum:

(a)Describe the state department's plan for operating the program;

(b)Demonstrate how the prescription drugs imported into the state under the program will meet the applicable federal and state standards for safety, effectiveness, misbranding, and adulteration;

(c)Include a list of prescription drugs that have the highest potential for cost savings to the state through importation at the time that the request is submitted;

(d)Estimate the tota

Free access — add to your briefcase to read the full text and ask questions with AI

(1) On or before September 1, 2020, the
state department shall submit a request to the United States secretary of health
and human services for approval of the program under 21 U.S.C. sec. 384. The state
department shall begin operating the program not later than six months after
receiving such approval. The request must, at a minimum:

(a) Describe the state department's plan for operating the program;

(b) Demonstrate how the prescription drugs imported into the state under
the program will meet the applicable federal and state standards for safety,
effectiveness, misbranding, and adulteration;

(c) Include a list of prescription drugs that have the highest potential for cost
savings to the state through importation at the time that the request is submitted;

(d) Estimate the total cost savings attributable to the program; and

(e) Include a list of potential Canadian suppliers from which the state would
import prescription drugs and demonstrate that the suppliers are in full compliance
with relevant Canadian federal and provincial laws and regulations.

(2) Notwithstanding any provision of this part 2 to the contrary, the state
department may expend money for the purpose of requesting approval of the
program as described in subsection (1) of this section but the state department
shall not spend any other money to implement the program until the state
department receives approval of the program as described in said subsection (1).

(3) Upon receipt of federal approval of the program, the state department
shall notify the president of the senate and the speaker of the house of
representatives, as well as the health and human services committee of the senate
and the health and insurance committee of the house of representatives, or any
successor committees. After approval is received and before the start of the next
regular session of the general assembly in which the proposal could be funded, the
state department shall submit to all parties specified in this subsection (3) a
proposal for program implementation and program funding.